FDA Analysis Shows J&J’s COVID-19 Vaccine Is Effective

The United States Food and Drug Administration (FDA) released its own analysis of Johnson & Johnson’s (J&J) one-shot, easily stored COVID-19 vaccine, finding that the immunization protects against severe COVID-19 illness and death, and may limit spread of the novel coronavirus. Released on February 24, the report cites a 72% rate of effectiveness overall and an 86% rate of effectiveness against severe COVID-19 illness. The FDA is expected to issue an Emergency Use Authorization for the J&J vaccine by Saturday, February 27. Click here to read more.